Fresenius agrees two acquisitions to bolster Kabi drugs unit
The German healthcare group said today it would acquire a 55 per cent stake in mAbxience, a maker of affordable biosimilar…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.